Shenzhen Regis Biotechnology Co., Ltd., established on 2019-09-11, Business scope includes general business items:Biological product,Technology development in the field of medical technology,technology transfer,Technical Services,technical consulting;Development and technology transfer of medical technology,Daily necessities,Chemical raw materials and products(Removal of hazardous chemicals,Monitor Chemicals,civilian explosives,precursor chemicals)promotion of;Import and export of goods and technology.(law,Administrative regulations,Except for items prohibited by the State Council,Restricted projects must obtain a license before operating),The licensing program is:

Nuchido Ltd was established to address the growing consumer demand for cosmeceutical products. Cosmeceuticals are the combination of cosmetics and pharmaceuticals, and are cosmetic products with bioactive ingredients that are validated by the science community. A

SeekGene is a provider of genetic data analysis solutions focused on the development and clinical transformation of single cell sorting assays. The SeekGene operations team has many years of research and clinical service experience, focusing on the application of single-cell sequencing technology in real-world clinical research. Its self-developed high-throughput single-cell transcriptome sequencing kit achieves world-leading performance, and is flexible, simple, economical, and accurate, which can accelerate the clinical transformation of single-cell sequencing technology.

CEA is a French government-funded technological research organisation. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world. The CEA is the French Alternative Energies and Atomic Energy Commission (Commissariat à l'énergie atomique et aux énergies alternatives). It is a public body established in October 1945 by General de Gaulle. A leader in research, development and innovation, the CEA mission statement has two main objectives: To become the leading technological research organization in Europe and to ensure that the nuclear deterrent remains effective in the future. The CEA is active in four main areas: low-carbon energies, defense and security, information technologies and health technologies. In each of these fields, the CEA maintains a cross-disciplinary culture of engineers and researchers, building on the synergies between fundamental and technological research. The total CEA workforce consisted of 15 838 employees. Across the whole of the CEA (including both civilian and military research), there were 1556 PhD students and 293 post-docs. The CEA is based in ten research centers in France, each specializing in specific fields. The laboratories are located in the Paris region, the Rhône-Alpes, the Rhône valley, the Provence-Alpes-Côte d'Azur region, Aquitaine, Central France and Burgundy. The CEA benefits from the strong regional identities of these laboratories and the partnerships forged with other research centers, local authorities and universities.

Assistance Publique des Hôpitaux de Paris SA the company is headquartered in Paris, France.

Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France.

Beijing Dingcheng Peptide Source Biotechnology Co., Ltd., established on 2014-03-26, Business scope includes biological,Pharmaceutical technology development,technology transfer,technical consulting,Technical Services;Sales of biological reagents(Free of Hazardous Chemicals,medicine).(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Peking University Third Hospital is a private company headquartered in Beijing, China, that operates as a clinic.

Chengdu Shiji Bio-Pharmaceutical Co., Ltd., established on 2003-04-15, Business scope includes licensed projects:Veterinary drug production;Veterinary drug business;Breeding livestock and poultry management(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Agricultural Science Research and Experimental Development;Bio-feed R&D;Pet Food and Supplies Wholesale;Pet food and supplies retail;Experimental analysis instrument sales;Specialty Chemicals Sales(Free of Hazardous Chemicals);Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;internet sales(Except for products that require a license for sale);Import and export;Technology Import and Export;Import and export agency;farming,Forest,animal husbandry,vice,Sales of fishery specialized machinery(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).

Shenzhen Zhongshan Urological Hospital, part of Sichuan Jinxin Reproductive Medical Investment Management Co, is a Chinese company located in Shenzhen that provides healthcare services. The firm was founded in 2004. Jiang Lin Deng is currently the CEO of the company.

ABclonal Technology is a rapidly growing life science research and diagnostic reagents provider. With scientists from world-class universities, the company thrives on improving the quality of life science research by providing high-quality antibodies, proteins, ELISA kits, NGS library preparation kits and molecular enzymes.

Zhejiang Puhui Medical Technology Co., Ltd., established on 2019-01-18, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Human stem cell technology development and application;Biochemical product technology research and development;Health Consulting Services(Does not include medical services);Health Care Services(non-medical);hospital management;Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Sales of hygiene products and single-use medical products;Specialty Chemicals Sales(Free of Hazardous Chemicals)(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).licensed items:medical service;Health food production;Drug Wholesale;pharmaceutical production;Health food sales;Drug import and export;Import and export;Technology Import and Export(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).

Chengdu Aiweifu Biotechnology Co., Ltd., established on 2017-01-25, Business scope includes biotechnology development,technical consulting,Technical Services,technology transfer;software development;Instrumentation,chemical reagent,Polymer Materials,Research and development of active equipment and consumables,Production,Sales;Medical device research and development.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments).Medical device production,Sales.(Did not obtain the relevant administrative license(approval),Do not carry out business activities).

Institut du Cerveau et de la Moelle ��pini��re is a French private company located in Paris. The firm engages in spinal cord and brain research and educational services. It was founded by Maurice L��vy and Serge Weinberg.

Ma'anshan Shiji Animal Health Management Co., Ltd., established on 2015-12-22, Business scope includes animal disease prevention and control technology,Technology development in the field of biotechnology,Technical Services,technical consulting,technology transfer;Veterinary Drug Sales,Veterinary biological reagents,Development of medical reagents.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Readline is a bio-pharmaceutical high-tech company with a multidisciplinary application based on enzyme catalysis technology. It is the world's first company to use directed evolution of enzymes in the large-scale production of API such as peptides, carbohydrate, and nucleic acids on an all-green basis. These APIs are primarily used in medicine, health care products, cosmetics, animal feed, biological pesticides, fertilizers, and other applications.

Shenzhen Boao Kang Biotechnology Co., Ltd., established on 2013-11-04, Business scope includes general business items:Research on Biotechnology Products,Biological product,biotechnology products,Development of biochemical scientific research reagents and related technical services,Biochemical Research Instruments,Reagent,Sales of laboratory consumables;Operating Class II medical devices;Domestic Trade(Does not contain franchise,monopoly,Specially Controlled Commodities);Operating import and export business(law,Administrative regulations,Except for items prohibited by the State Council,Restricted projects must obtain a license before operating).,The licensing program is: